McKesson Corporation (MCK)
| Market Cap | 73.24B |
| Revenue (ttm) | 308.95B |
| Net Income (ttm) | 3.00B |
| Shares Out | 129.99M |
| EPS (ttm) | 22.39 |
| PE Ratio | 25.21 |
| Forward PE | 17.88 |
| Dividend | $2.48 (0.44%) |
| Ex-Dividend Date | Jun 3, 2024 |
| Volume | 344,292 |
| Open | 559.45 |
| Previous Close | 555.76 |
| Day's Range | 557.93 - 564.87 |
| 52-Week Range | 373.28 - 566.01 |
| Beta | 0.45 |
| Analysts | Strong Buy |
| Price Target | 569.13 (+0.82%) |
| Earnings Date | May 7, 2024 |
About MCK
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty ... [Read more]
Financial Performance
In 2023, McKesson's revenue was $308.95 billion, an increase of 11.65% compared to the previous year's $276.71 billion. Earnings were $3.00 billion, a decrease of -15.67%.
Financial StatementsAnalyst Forecast
According to 15 analysts, the average rating for MCK stock is "Strong Buy." The 12-month stock price forecast is $569.13, which is an increase of 0.82% from the latest price.
News
McKesson misses quarterly estimates as US pharmaceuticals segment weighs
McKesson Corp reported weaker-than-expected quarterly revenue and profit on Tuesday due to slump in demand for the company's branded and specialty drugs that dragged sales in its U.S. pharmaceutical s...
McKesson Corporation Reports Fiscal 2024 Fourth Quarter and Full Year Results
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 fourth quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve...
McKesson Corporation Declares Quarterly Dividend
IRVING, Texas--(BUSINESS WIRE)--The Board of Directors of McKesson Corporation (NYSE:MCK) yesterday declared a regular dividend of 62 cents per share of common stock. The dividend will be payable on J...
McKesson Launches Project Oasis to Address Pharmacy Deserts in Underserved Communities
IRVING, Texas--(BUSINESS WIRE)--McKesson launches Project Oasis, a new initiative aimed at advancing health equity for at-risk populations in underserved communities.
McKesson Corporation Announces Fourth Quarter Fiscal 2024 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its fourth quarter and full year fiscal 2024 financial results after market close on Tuesday, May 7, 2024. The company wil...
Rite Aid reaches bankruptcy settlement with lenders, DOJ, McKesson
Pharmacy chain Rite Aid has reached a settlement with its lenders, the U.S. Department of Justice, and drug supplier McKesson Corp , clearing a path for Rite Aid to complete its bankruptcy case by lat...
McKesson Invites Community Pharmacists to Push the Industry Forward, Together
IRVING, Texas--(BUSINESS WIRE)--Register for McKesson ideaShare, a premier community pharmacy annual education and networking event, in New Orleans from June 23-26, 2024.
McKesson's Practice Insights Designated as a 2024 Qualified Clinical Data Registry by Centers for Medicare & Medicaid Services
IRVING, Texas--(BUSINESS WIRE)--McKesson received approval from CMS to participate in the Merit-based Incentive Payment System as a Qualified Clinical Data Registry for the 8th year.
McKesson raises annual profit forecast on strong demand for specialty medicines
U.S.-based drug distributor McKesson raised its annual profit forecast on Wednesday, banking on strong demand for specialty medicines.
McKesson Corporation Reports Fiscal 2024 Third Quarter Results and Raises Full Year Guidance
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 third quarter financial results. Results can be accessed on McKesson's Investor Relations website at inves...
Charts turn bullish on health-care stocks as sector takes early lead in 2024
Chart-watchers are growing increasingly bullish on health-care stocks now that they have become the best-performing sector of the S&P 500 so far in 2024, according to Dow Jones Market Data. Analysts h...
US drug retailer McKesson seeks buyers for Canada's Rexall Pharmacy -source
McKesson Corp is planning to sell Canadian drugstore chain Rexall Pharmacy Group, a source familiar with the process told Reuters on Friday, seven years after the U.S. drug distributor bought the busi...
McKesson to Present at the 42nd Annual J.P. Morgan Healthcare Conference
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will present at the 42nd Annual J.P. Morgan Healthcare Conference at the Westin St. Francis Hotel in San Francisco today at 9:45 AM PT ...
McKesson Corporation Announces Third Quarter Fiscal 2024 Earnings Release Date and Participation in January Conference
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its third quarter fiscal 2024 financial results after market close on Wednesday, February 7, 2024. The company will host a...
Edifecs Appoints Former McKesson Leader, Stephen Ayers, as Chief Financial Officer
BELLEVUE, Wash.--(BUSINESS WIRE)--Edifecs, Inc., a global health information technology solutions company, announced today the addition of Stephen Ayers to its leadership team as chief financial offic...
McKesson lifts annual profit forecast after strong quarterly results
Drug distributor McKesson Corp on Wednesday raised its annual profit forecast, banking on strong demand for specialty medicines.
McKesson Corporation Reports Fiscal 2024 Second Quarter Results and Raises Full Year Guidance
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) has released its fiscal 2024 second quarter financial results. Results can be accessed on McKesson's Investor Relations website at inve...
McKesson Aims For The $500 Milestone After Shattering Previous Record Highs And Outperforming The S&P 500! - McKesson (NYSE:MCK)
McKesson Corp's MCK impressive performance stands out amidst a decline in the S&P 500 index.
Bankrupt Rite Aid resolves drug supply dispute with McKesson
Pharmacy chain Rite Aid has settled a critical dispute with drug supplier McKesson Corp to ensure that customers' prescriptions will continue to be filled during Rite Aid's bankruptcy, attorneys said ...
McKesson doesn't expect Rite Aid's bankruptcy to have much affect on profit outlook, liquidity
McKesson Corp. MCK, +0.73% disclosed Monday that it doesn't expect drugstore chain Rite Aid Corp.'s RAD, -16.81% bankruptcy announced over the weekend to have a material impact on its adjusted earning...
McKesson Corporation Announces Second Quarter Fiscal 2024 Earnings Release Date
IRVING, Texas--(BUSINESS WIRE)--McKesson Corporation (NYSE: MCK) will release its second quarter fiscal 2024 financial results after market close on Wednesday, November 1, 2023. The company will host ...
Genpact Extends Relationship to Transform McKesson's Finance Operations for Enhanced Service and Competitive Growth
Companies co-innovate with leading-edge technologies, advanced analytics, and improved process design to drive strategic business value with McKesson's digital finance operating model optimization IR...
Buffett bet on home builders and retreated from videogames during the second quarter
Warren Buffett's Berkshire Hathaway Inc. took new stakes in home builders, bulked up on Capital One Financial Corp. and backed away from Activision Blizzard Inc. in the second quarter, according to qu...
Warren Buffett's Berkshire Hathaway bet on 3 homebuilders - and sold and slashed a bunch of stocks last quarter
Warren Buffett's Berkshire Hathaway added a trio of homebuilders to its portfolio last quarter. The investor's company exited three stocks and slashed several of its positions, SEC filings show.